￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Lorlatinib/lorlatinib is developed and produced by which company

2026-02-01 22:25:32

Check Details
Mechanism of resistance to Gefapixant Citrate

2026-02-01 22:25:32

Check Details
Main indications and clinical application directions of Stiripentol

2026-02-01 22:25:32

Check Details
Interpretation of medical insurance reimbursement policy for Futibatinib

2026-02-01 22:25:32

Check Details
Mitapivat-Pyrukynd dosage adjustment and usage recommendations

2026-02-01 22:25:32

Check Details
Introduction to specifications and packaging information of Pegcetacoplan-Empaveli

2026-02-01 22:25:32

Check Details
The R&D process of Maribavir’s original manufacturer

2026-02-01 22:25:32

Check Details
Evaluation of clinical efficacy of Gefapixant Citrate

2026-02-01 22:25:32

Check Details
Latest market price reference information for Stiripentol in 2026

2026-02-01 22:25:32

Check Details
Futibatinib dose adjustment principles guide

2026-02-01 22:25:32

Check Details
Medication contraindications and precautions for mitapivat-Pyrukynd

2026-02-01 22:25:32

Check Details
Pegcetacoplan-Empaveli purchase methods and channel recommendations

2026-02-01 22:25:32

Check Details
Category
相关知识